• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 40-F filed by Nutrien Ltd.

    2/27/26 12:41:17 PM ET
    $NTR
    Agricultural Chemicals
    Industrials
    Get the next $NTR alert in real time by email
    40-F
    false0001725964FY20250001725964dei:BusinessContactMember2025-01-012025-12-31

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    FORM 40-F

    [Check one]

    

    REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934

    OR

    

    ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    For the fiscal year ended December 31, 2025

    Commission File Number 001-38336

    NUTRIEN LTD.

    (Exact name of Registrant as specified in its charter)

    Canada

    (Province or other jurisdiction of incorporation or organization)

    2870

    (Primary Standard Industrial Classification Code Number (if applicable))

     

    98-1400416

    (I.R.S. Employer Identification Number (if applicable))

    Suite 1700, 211 19th Street East

    Saskatoon, Saskatchewan, Canada

    S7K 5R6

    (306) 933-8500

    (Address and telephone number of Registrant’s principal executive offices)

     

    CT Corporation System

    28 Liberty St.

    New York, NY  10005

    (212) 894-8940

    (Name, address (including zip code) and telephone number (including area code)
    of agent for service in the United States)

    Securities registered or to be registered pursuant to Section 12(b) of the Securities Exchange Act of 1934 (“Exchange Act”):

    Title of each class

    Trading Symbol(s)

    Name of each exchange on which registered

    Common Shares

    NTR

    New York Stock Exchange

    Securities registered or to be registered pursuant to Section 12(g) of the Exchange Act:

    Not Applicable
    (Title of Class)

     

     


    Securities for which there is a reporting obligation pursuant to Section 15(d) of the Exchange Act:

    Not Applicable

    (Title of Class)

     

    For annual reports, indicate by check mark the information filed with this Form:

     Annual information form

     

     Audited annual financial statements

    Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report.

    481,962,233 Common Shares outstanding as of December 31, 2025

    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

     Yes  No

    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

     Yes  No

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.

     Emerging growth company

    If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. 

    † The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

    Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. 

    If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. 

    Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). 

    This Annual Report on Form 40-F shall be incorporated by reference into the Registration Statements on Form S-8 (File Nos. 333-222384, 333-222385 and 333-226295) of the registrant.  In addition, the registrant’s Annual Information Form; Management’s Discussion and Analysis; Audited Annual Consolidated Financial Statements for the fiscal year ended December 31, 2025, including Management’s Annual Report on Internal Control over Financial Reporting; Consent of KPMG LLP, Independent Registered Public Accounting Firm; Consent of Craig Funk, B.Sc., M.Sc., P.Eng., P.Geo.; and Consent of Jodi Derkach, B.Sc., P.Geo., included as Exhibits 99.1, 99.2, 99.3, 99.4, 99.8 and 99.9, respectively, to this Annual Report on Form 40-F, are incorporated by reference into and as an exhibit to the registrant’s Registration Statement on Form F-10 (File No. 333-278180).

    Principal documents

    The following documents have been filed as part of this Annual Report:

     

     


    1. Annual Information Form for the fiscal year ended December 31, 2025 (the “2025 AIF”) (filed as Exhibit 99.1 hereto);
    2. Management’s Discussion and Analysis for the fiscal year ended December 31, 2025 (the “2025 MD&A”) (filed as Exhibit 99.2 hereto); and
    3. Audited Annual Financial Statements, including the Reports of Independent Registered Public Accounting Firm, for the fiscal year ended December 31, 2025 (the “2025 Audited Annual Financial Statements”) (filed as Exhibit 99.3 hereto).

    CONTROLS AND PROCEDURES

         A.     Certifications

    The required disclosure is included in Exhibits 99.5, 99.6 and 99.7 to this Annual Report, and is incorporated herein by reference.

         B.     Evaluation of Disclosure Controls and Procedures

    The required disclosure is included in “Controls and Procedures—Disclosure Controls and Procedures” in the 2025 MD&A, filed as Exhibit 99.2 to this Annual Report, and is incorporated herein by reference.

         C.     Management’s Annual Report on Internal Control over Financial Reporting

    Management is responsible for establishing and maintaining an adequate system of internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended. The required disclosure is included in “Management’s Responsibility—Management’s Annual Report on Internal Control Over Financial Reporting” that accompanies the 2025 Audited Annual Financial Statements, filed as Exhibit 99.3 to this Annual Report, and is incorporated herein by reference.

         D.     Attestation Report of the Independent Registered Public Accounting Firm

    The required disclosure is included in the “Report of Independent Registered Public Accounting Firm” that accompanies the 2025 Audited Annual Financial Statements, filed as Exhibit 99.3 to this Annual Report, and is incorporated herein by reference.

         E.     Changes in Internal Control over Financial Reporting

    During the period covered by this report, there was no change in Nutrien’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting. For further information, see “Controls and Procedures—Internal Control over Financial Reporting” in the 2025 MD&A, filed as Exhibit 99.2 to this Annual Report and incorporated herein by reference.

     

    IDENTIFICATION OF THE AUDIT COMMITTEE

    The Board has a separately-designated standing audit committee established in accordance with section 3(a)(58)(A) of the Exchange Act. The members of the Audit Committee are Christopher M. Burley, Miranda C. Hubbs, Raj S. Kushwaha, Julie A. Lagacy, Consuelo E. Madere, and Aaron W. Regent.

    AUDIT COMMITTEE FINANCIAL EXPERT

    The Nutrien Board of Directors (the “Board”) has determined that it has at least one “audit committee financial expert” (as such term is defined in paragraph 8(b) of General Instruction B to Form 40-F) serving on its Audit Committee. Mr. Christopher M. Burley has been determined to be such audit committee financial expert and was “independent” as such term is defined under the Canadian Securities Administrators’ National Instrument 52-110—Audit Committees and the standards of the U.S. Securities and Exchange Commission (the “SEC”) and the New York Stock Exchange (the “NYSE”) relating to the independence of audit committee members.

     

     


    The Board’s designation of Mr. Christopher M. Burley as an audit committee financial expert does not impose on him any duties, obligations or liability that are greater than the duties, obligations and liability imposed on him as a member of the Audit Committee and Board in the absence of such designation or identification.  In addition, the designation of Mr. Christopher M. Burley as an audit committee financial expert does not affect the duties, obligations or liability of any other member of the Audit Committee or Board. See also “17—Audit Committee” of Nutrien’s 2025 AIF, filed as Exhibit 99.1 to this Annual Report, and incorporated herein by reference.

    COMPLIANCE WITH NYSE LISTING STANDARDS ON CORPORATE

    GOVERNANCE

    Our common shares are listed on the NYSE, but as a listed foreign private issuer, the NYSE does not require us to comply with all of its listing standards regarding corporate governance. Notwithstanding this exemption, we are in compliance in all material respects with the NYSE listing standards and we intend to continue to comply with such standards so as to ensure that there are no significant differences between our corporate governance practices and those practices required by the NYSE of other publicly listed companies.

     

    CODE OF CONDUCT AND ETHICS

    Nutrien has adopted a “code of ethics” (as that term is defined in Form 40-F), entitled the Nutrien Code of Conduct that applies to all directors, officers, employees and representatives of Nutrien and its subsidiaries (the “Nutrien Code”). A copy of the Nutrien Code is posted on Nutrien’s website at https://www.nutrien.com/what-we-do/governance. Copies may be obtained, free of charge, by contacting Nutrien in writing at 211 19th Street East, Suite 1700, Saskatoon, Saskatchewan, Canada S7K 5R6, by telephone at (306) 933-8500 or on Nutrien’s website at www.nutrien.com. Nutrien intends to post any amendments to and waivers from the Nutrien Code on its website as identified above.

    NOTICES PURSUANT TO REGULATION BTR

    Not applicable.

    PRINCIPAL ACCOUNTANT FEES AND SERVICES

    The following table sets out the fees billed to Nutrien by KPMG LLP  (PCAOB ID: 85; Calgary, AB, Canada) and its affiliates for professional services rendered during the years ended December 31, 2025 and 2024. During these years, KPMG LLP was the Company’s only external auditor.

    Category

    Years Ended December 31 (US$)

     

     

    2025

     

    2024

    Audit Fees 1

    10,809,000

     

    9,877,400

    Audit-Related Fees 2

    79,700

     

    73,700

    Tax Fees 3

    70,600

     

    44,500

    All Other Fees 4

    399,300

     

    226,400

    Total

    11,358,600

     

    10,222,000

    1.           For professional services rendered by KPMG LLP for the integrated audit of the Company’s annual financial statements; interim review of the Company’s interim financial statements; audits of statutory financial statements of controlled subsidiaries; attestation reporting in accordance with US environmental agency requirements and consent orders; attestation reports over various Nutrien subsidiaries for the purpose of compliance with local laws and regulations; and work in connection with the renewal of the Company’s base shelf prospectus in 2025 and the Company’s prospectus supplements relating to the offering of senior notes in 2025 and 2024.
    2.           For professional services rendered by KPMG LLP for translation of the Company’s annual and quarterly reports and in connection with an audit of the financial statements of an employee benefit plan.
    3.           For professional services rendered by KPMG LLP for assistance with preparation and review of tax filings and related tax compliance, assistance in responding to tax authorities, including reassessments and tax audits, routine tax planning and advice.
    4.           For professional services rendered by KPMG LLP for the preparation of subsidiary statutory financial statements; an assessment of the Company’s cyber-security maturity level against a globally recognized framework and a readiness assessment for assurance over the Company’s report on cyber security key performance indicators; limited assurance over Nutrien Scope 1, Scope 2 and Scope 3 GHG emissions; and precondition readiness for Scope 1, Scope 2 and Scope 3 assurance; and general training on financial accounting and reporting or regulatory matters.

     

     


    AUDIT COMMITTEE’S PRE-APPROVAL POLICIES AND PROCEDURES

    The required disclosure is included in “17—Audit Committee-17.4—Pre-approval Policies and Procedures” of Nutrien’s 2025 AIF, filed as Exhibit 99.1 to this Annual Report, and incorporated herein by reference.

    OFF-BALANCE SHEET ARRANGEMENTS

    The information included in “Other Financial Information—Off-Balance Sheet Arrangements” of the 2025 MD&A, filed as Exhibit 99.2 to this Annual Report, is incorporated herein by reference.

    TABULAR DISCLOSURE OF CONTRACTUAL OBLIGATIONS

    The information included in “Liquidity and Capital Resources—Cash Requirements” of the 2025 MD&A, filed as Exhibit 99.2 to this Annual Report, is incorporated herein by reference.

    RESERVE AND RESOURCE ESTIMATES

    The disclosure included in or incorporated by reference in this Annual Report uses mineral reserves and mineral resources classification terms that comply with reporting standards in Canada and are made in accordance with National Instrument 43-101—Standards of Disclosure for Mineral Projects (“NI 43-101”), which references the Canadian Institute of Mining, Metallurgy and Petroleum Definition Standards on Mineral Resources and Mineral Reserves. NI 43-101 is a rule developed by the Canadian Securities Administrators that establishes standards for all public disclosure an issuer makes of scientific and technical information concerning mineral projects.

    These standards differ from the requirements of the SEC that are applicable to domestic United States reporting companies. Any mineral reserves and mineral resources reported by the Company in accordance with NI 43-101 may not qualify as such under SEC standards. Accordingly, information included in this Annual Report and the documents incorporated by reference herein that describes the Company’s mineral reserves and mineral resources estimates may not be comparable with information made public by United States companies subject to the SEC’s reporting and disclosure requirements.

    MINE SAFETY DISCLOSURE

    The information concerning mine safety violations or other regulatory matters required by Section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 16 of General Instruction B to Form 40-F is included in Exhibit 99.10 to this Annual Report.

    DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

    Not applicable.

    RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION

    Not applicable.

    WEBSITE INFORMATION

    Notwithstanding any reference to Nutrien’s website or other websites on the World Wide Web in this Annual Report or in the documents attached as exhibits hereto, the information contained in Nutrien’s website or any other website on the World Wide Web referred to in this Annual Report or in the documents attached as exhibits hereto, or referred to in Nutrien’s website, is not a part of this Annual Report and, therefore, is not filed with the SEC.

    UNDERTAKING AND CONSENT TO SERVICE OF PROCESS

    The Registrant undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the SEC staff, and to furnish promptly, when requested to do so by the SEC staff, information relating to: the securities registered pursuant to Form 40-F; the securities in relation to which the obligation to file an annual report on Form 40-F arises; or transactions in said securities.

     

     


    The Registrant has previously filed an Appointment of Agent for Service of Process and Undertaking on Form F-X with respect to the class of securities in relation to which the obligation to file the Form 40-F arises. Any change to the name or address of the Registrant’s agent for service of process shall be communicated promptly to the SEC by amendment to the Form F-X referencing the file number of the Registrant.

     

    SIGNATURES

    Pursuant to the requirements of the Exchange Act, the Registrant certifies that it meets all of the requirements for filing on Form 40-F and has duly caused this annual report to be signed on its behalf by the undersigned, thereto duly authorized.

    NUTRIEN LTD.

     

     

    By:

    /s/ Noralee Bradley

    Name:

    Title:

    Noralee Bradley

    Executive Vice President

    External Affairs Chief Legal Officer and Corporate Secretary

     

    Date: February 27, 2026

     

     


    EXHIBIT INDEX

    Exhibit Number

    Description

    97.1

    Compensation Recovery Policy (incorporated by reference to Exhibit 97.1 of Nutrien Ltd.’s Annual Report on Form 40-F for the year ended December 31, 2023 filed on March 1, 2024)

    99.1

    Annual Information Form for the fiscal year ended December 31, 2025

    99.2

    Management’s Discussion and Analysis for the fiscal year ended December 31, 2025

    99.3

    Audited Annual Consolidated Financial Statements for the fiscal year ended December 31, 2025

    99.4

    Consent of KPMG LLP, Independent Registered Public Accounting Firm

    99.5

    Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

    99.6

    Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

    99.7

    Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

    99.8

    Consent of Craig Funk, B.Sc., M.Sc., P.Eng., P.Geo.

    99.9

    Consent of Jodi Derkach, B.Sc., P.Geo.

    99.10

    Mine Safety Disclosure

    101

    Interactive Data File (formatted as Inline XBRL)

    104

    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

     

     

     

    Get the next $NTR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NTR

    DatePrice TargetRatingAnalyst
    2/23/2026Outperform → Neutral
    BNP Paribas Exane
    1/14/2026$77.00Equal-Weight → Overweight
    Morgan Stanley
    11/11/2025$64.00Equal Weight
    Wells Fargo
    10/14/2025$67.00Buy → Neutral
    BofA Securities
    9/5/2025Sector Perform
    National Bank Financial
    7/11/2025$66.00Buy → Hold
    Jefferies
    6/17/2025$68.00Outperform → Mkt Perform
    Raymond James
    5/14/2025$62.00Sector Outperform → Sector Perform
    Scotiabank
    More analyst ratings

    $NTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nutrien Files 2025 Annual Disclosures

    Nutrien Ltd. (TSX and NYSE:NTR) announced today that its 2025 Annual Report, including Management's Discussion and Analysis and Audited Consolidated Financial Statements, as well as its Annual Information Form are available on the EDGAR section of the US Securities and Exchange Commission's website at www.sec.gov and the Canadian Securities Administrators' website at www.sedarplus.ca. The 2025 Annual Report provides an update on Nutrien's strategy, market environment, governance and key enterprise risks, financial results and outlook. Nutrien also released its 2025 Sustainability Report today, detailing its sustainability initiatives and performance. The reports can be reviewed and down

    2/27/26 1:10:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces TSX Approval for Its Renewed Share Repurchase Program

    Nutrien Ltd. (TSX and NYSE:NTR) announced today that the Toronto Stock Exchange (TSX) has accepted Nutrien's notice to commence a normal course issuer bid (NCIB) to purchase outstanding common shares representing up to five percent of its issued and outstanding common shares. Under the NCIB, purchases of common shares may be made through the facilities of the TSX, the New York Stock Exchange and/or alternative trading systems in Canada and the U.S., or as otherwise permitted under applicable securities laws. The actual number of common shares that may be purchased under the NCIB and the timing of any such purchases will be determined by Nutrien. Nutrien believes that purchasing its own co

    2/26/26 5:45:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Attendance at the BMO and BofA Investor Conferences

    Nutrien Ltd. (TSX and NYSE:NTR) announced today that Mr. Ken Seitz, Nutrien's President and Chief Executive Officer, will be speaking at the BMO 35th Global Metals, Mining and Critical Minerals Conference on Tuesday, February 24 at 8:00am EST. Additionally, Mr. Seitz and Mr. Mark Thompson, Nutrien's Executive Vice President and Chief Financial Officer will be speaking at the 2026 BofA Global Agriculture and Materials Conference on Wednesday, February 25 at 7:30am EST. The fireside chats for both conferences will be video cast and available on the Company's website at https://www.nutrien.com/investors/events. About Nutrien Nutrien is a leading global provider of crop inputs and servi

    2/20/26 1:00:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Nutrien downgraded by BNP Paribas Exane

    BNP Paribas Exane downgraded Nutrien from Outperform to Neutral

    2/23/26 8:33:10 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Nutrien from Equal-Weight to Overweight and set a new price target of $77.00

    1/14/26 8:22:27 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Wells Fargo resumed coverage on Nutrien with a new price target

    Wells Fargo resumed coverage of Nutrien with a rating of Equal Weight and set a new price target of $64.00

    11/11/25 8:06:04 AM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    SEC Filings

    View All

    SEC Form 6-K filed by Nutrien Ltd.

    6-K - Nutrien Ltd. (0001725964) (Filer)

    2/27/26 2:23:25 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by Nutrien Ltd.

    6-K - Nutrien Ltd. (0001725964) (Filer)

    2/27/26 1:29:42 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by Nutrien Ltd.

    6-K - Nutrien Ltd. (0001725964) (Filer)

    2/27/26 12:44:15 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    Financials

    Live finance-specific insights

    View All

    Nutrien Reports Full-Year 2025 Results and Provides 2026 Guidance

    Full-year results demonstrate strong execution of our strategic plan and progress towards 2026 performance targets. 2026 guidance reflects growth in upstream fertilizer sales volumes from our North American plants, higher Retail earnings, and a disciplined and consistent approach to capital allocation. All amounts are in US dollars, except as otherwise noted Nutrien Ltd. (TSX and NYSE:NTR) announced today its fourth quarter 2025 results, with net earnings of $0.58 billion ($1.18 diluted net earnings per share). Fourth quarter 2025 adjusted EBITDA1 was $1.28 billion and adjusted net earnings per share1 was $0.83. "2025 was a defining year for our Company, with exceptional performa

    2/18/26 5:26:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Increases Quarterly Dividend and Announces Intent to Launch a New Share Repurchase Program

    Nutrien Ltd. (TSX and NYSE:NTR) announced today that its Board of Directors declared a quarterly dividend of US$0.55 per share payable on April 16, 2026 to shareholders of record on March 31, 2026. This represents an approximately one percent increase from the prior dividend declared on November 5, 2025 and equates to an annualized dividend of US$2.20 per share. The Board also approved the purchase of up to five percent of Nutrien's issued and outstanding common shares over a twelve-month period through a normal course issuer bid (NCIB). Any purchases of common shares will be subject to acceptance by the Toronto Stock Exchange of Nutrien's notice to commence a NCIB. Registered sharehold

    2/18/26 5:21:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Release Dates for Fourth Quarter 2025 Results and Conference Call

    Nutrien Ltd. (TSX and NYSE:NTR) announced today plans to release fourth quarter 2025 results after market close on Wednesday, February 18. Nutrien will host a conference call to discuss its results and outlook at 10:00 a.m. EST on Thursday, February 19. Investors can access the call by dialing 1-800-990-2777 or 1-416-855-9085 and using conference ID: 93473. A webcast of the call can be accessed by visiting Nutrien's Investor Events and Presentation page. A recording of the call will be available after its completion and can be accessed at: www.nutrien.com/investors/events. The webcast link will be live for 12 months following the call. About Nutrien Nutrien is a leading global provi

    1/20/26 6:00:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    $NTR
    Leadership Updates

    Live Leadership Updates

    View All

    Nutrien Announces Results of 2025 Annual Meeting

    Nutrien Ltd. (TSX and NYSE:NTR) announced today the results of its annual meeting of shareholders held on May 7, 2025 (the "Meeting"). A total of 488,556,988 common shares, representing 74.48% of common shares outstanding, were represented at the Meeting. Results of the matters voted on at the Meeting are set out below. Election of Directors Nutrien's 12 director nominees were elected: Votes For (percent) Votes Against (percent) Christopher M. Burley 98.02% 1.98% Maura J. Clark 98.88% 1.12% Russell K. Girling 96.64% 3.36% Michael J. Hennigan 96.21% 3.79% Miranda C. Hubbs 98.20% 1.80% Raj S. Kushwaha 98.88% 1.12%

    5/7/25 8:31:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Results of 2024 Annual Meeting

    Nutrien Ltd. (NYSE:NTR) announced today the results of its annual meeting of shareholders held on May 8, 2024 (the "Meeting"). A total of 369,251,444 common shares, representing 74.66% of common shares outstanding, were represented at the Meeting. Results of the matters voted on at the Meeting are set out below. Election of Directors Nutrien's 12 director nominees were elected: Votes For (percent) Votes Against (percent) Christopher M. Burley 98.33% 1.67% Maura J. Clark 98.95% 1.05% Russell K. Girling 98.31% 1.69% Michael J. Hennigan 94.88% 5.12% Miranda C. Hubbs 98.48% 1.52%

    5/8/24 7:11:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials

    Nutrien Announces Results of 2023 Annual Meeting

    Nutrien Ltd. (NYSE:NTR) announced today the results of its annual meeting of shareholders held on May 10, 2023 (the "Meeting"). A total of 386,934,221 common shares, representing 77.42% of common shares outstanding, were represented at the Meeting. Results of the matters voted on at the Meeting are set out below. Election of Directors Nutrien's 12 director nominees were elected: Votes For (percent) Votes Against (percent) Christopher M. Burley 95.86% 4.14% Maura J. Clark 95.57% 4.43% Russell K. Girling 93.30% 6.70% Michael J. Hennigan 91.15% 8.85% Miranda C. Hubbs 95.80% 4.20

    5/10/23 7:44:00 PM ET
    $NTR
    Agricultural Chemicals
    Industrials